News Archive
The University Hospital Cologne (UHC), in collaboration with the German Center for Infection Research (DZIF) has selected the Celonic Group for process development and GMP manufacturing of a monoclonal antibody
The University Hospital Cologne (UHC), in collaboration with the German...
Read More
Celonic AG and Leukocare AG Announce Development Collaboration to Support Joint Clients with Complex Biologics and Advanced Drug Product Profiles
Celonic AG and Leukocare AG Announce Development Collaboration to Support...
Read More
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver...
Read More
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based...
Read More
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS...
Read More
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) And Pilot Plant In Basel, Switzerland
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) And Pilot...
Read More
Celonic Launches New GS-CHOvolution® Cell Line Expression System
GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT...
Read More
Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic
BASEL, SWITZERLAND, August 1, 2023. Celonic Group, a Swiss-based Biologics...
Read More